Mycosis fungoides primary prevention

Cutaneous T cell lymphoma Microchapters
Home
Patient Information
Overview
Classification Mycosis fungoides Sezary syndrome
Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Overview

There are no established measures for the secondary prevention of mycosis fungoides but recommended effective measures for the secondary prevention of mycosis fungoides is follow up patients with active or progressive disease. every 4–6 weeks

Secondary Prevention

effective measures for the secondary prevention of mycosis fungoides is follow up patients with active or progressive disease. every 4–6 weeks.